Look for any podcast host, guest or anyone
Showing episodes and shows of

With Ochre Bio CSO And Co-founder Quin Wills

Shows

Citeline PodcastsCiteline PodcastsPrecision Medicine in Liver Treatment: The Ochre Bio ApproachOchre Bio co-founder and CSO Quin Wills spoke with In Vivo about the UK-based company's novel approach to finding and validating RNA therapies for chronic liver diseases.2025-04-2328 minThe Biotech Startups PodcastThe Biotech Startups Podcast🧬 Quin Wills - Ochre Bio - Part 4 | Quin’s Journey Through Y Combinator | The Role of Empathy in Team Dynamics | Adapting in a Shifting Biotech Industry | Ochre Bio’s Fundraising Journey & Future PlansAs a podcast listener, you can redeem exclusive discounts with a growing list of biotech vendors and get $500 off your first equipment lease by using promo code “TBSP” on https://www.excedr.com/rewards.Part 4 of 4. My guest for this week’s episode is Quin Wills, CSO and Co-Founder of Ochre Bio, a pioneering biotechnology company developing RNA therapies for chronic liver diseases. Using a combination of genomic deep phenotyping, precision RNA medicine, and testing in live human donor livers, Ochre is developing therapies for liver health challenges ranging from increasing donor liver supply to reducing cirrhos...2024-06-1322 minThe Biotech Startups PodcastThe Biotech Startups Podcast🧬 Quin Wills - Ochre Bio - Part 3 | University of Oxford’s Single Cell Consortium | The Pitfalls of Californian Entrepreneurships | Dinner Table Origins of Ochre Bio | The Laws that Guide Ochre BioAs a podcast listener, you can redeem exclusive discounts with a growing list of biotech vendors and get $500 off your first equipment lease by using promo code “TBSP” on https://www.excedr.com/rewards.Part 3 of 4. My guest for this week’s episode is Quin Wills, CSO and Co-Founder of Ochre Bio, a pioneering biotechnology company developing RNA therapies for chronic liver diseases. Using a combination of genomic deep phenotyping, precision RNA medicine, and testing in live human donor livers, Ochre is developing therapies for liver health challenges ranging from increasing donor liver supply to reducing cirrhosis complic...2024-06-1021 minThe Biotech Startups PodcastThe Biotech Startups Podcast🧬 Quin Wills - Ochre Bio - Part 2 | Pursuing Dual Masters at Oxford & Cambridge | Moving from Genomics to RNA Research | Balancing Academia & Entrepreneurship | The Challenges of Product-Market Fit in BiotechAs a podcast listener, you can redeem exclusive discounts with a growing list of biotech vendors and get $500 off your first equipment lease by using promo code “TBSP” on https://www.excedr.com/rewards.Part 2 of 4. My guest for this week’s episode is Quin Wills, CSO and Co-Founder of Ochre Bio, a pioneering biotechnology company developing RNA therapies for chronic liver diseases. Using a combination of genomic deep phenotyping, precision RNA medicine, and testing in live human donor livers, Ochre is developing therapies for liver health challenges ranging from increasing donor liver supply to reducing cirrhosis complic...2024-06-0620 minThe Biotech Startups PodcastThe Biotech Startups Podcast🧬 Quin Wills - Ochre Bio - Part 1 | Childhood Moments in Johannesburg | A Passion for Science Grows with an Evolving Society | Academic Experience in Biology and Genetics | Exposure to Bioinformatics and Big DataAs a podcast listener, you can redeem exclusive discounts with a growing list of biotech vendors and get $500 off your first equipment lease by using promo code “TBSP” on https://www.excedr.com/rewards.Part 1 of 4. My guest for this week’s episode is Quin Wills, CSO and Co-Founder of Ochre Bio, a pioneering biotechnology company developing RNA therapies for chronic liver diseases. Using a combination of genomic deep phenotyping, precision RNA medicine, and testing in live human donor livers, Ochre is developing therapies for liver health challenges ranging from increasing donor liver supply to reducing cirrhos...2024-06-0318 minAWS Health Innovation PodcastAWS Health Innovation Podcast#81, Thinking Big to Improve Liver Disease Outcomes, Quin Wills from Ochre Bio Using a combination of deep analysis of liver genetics and precision RNA design, Ochre Bio is developing breakthrough RNA therapies for chronic liver diseases like hepatitis, cirrhosis and liver cancer. On this episode of the AWS Health Innovation Podcast, host Dr. Terence Tan speaks with Ochre Bio Co-Founder & CSO Quin Wills about the company's unique approach to treating liver disease.We cover:Transdisciplinary ScienceOchre Bio believes combining deep expertise across genetics, computer science, and math enables the company to accelerate liver disease research.RNA TherapiesOchre Bio selected...2024-03-2027 minTomorrowScale PodcastTomorrowScale PodcastFrom Bile to Trial - Ochre BioOn this episode, Ochre Bio co-founders join us to discuss turning discarded organs into a goldmine of biological insight with deep phenotypics that enables the company to pan for fine-grained gene expression across millions of individual cells from different locations across an organ, and connect those signals to specific disease processes within cells. The need Ochre Bio is addressing initially is literally piling up, but is still difficult to access. Every year, tens of thousands of organs are recovered for human transplantation, but a huge number—thousands of livers, kidneys, and other organs—are evaluated as unfit for...2021-10-2252 minQA Selling Online at AmazonQA Selling Online at AmazonTarik Berrada Co-founder and CSO at Chez M19 an AI-Powered Advertising Technology for Amazon sellers.Tarik Berrada Co-founder and CSO at Chez M19 an AI-Powered Advertising Technology for Amazon sellers. Are you in ParisTarik you are a data scientist?When did you realize you had a passion for data?How did all this get started?I see you have at m19 people who used to work at Google and a few ex Criteo and even a Former Senior Manager at Amazon Advertising, how did the team get together?I tried some ai companies before but one didn't even have ai, just bulk If then statements all performed once every 24 hours at 4 AmWhat do you love...2021-02-1738 minPodcast Archives - QA Selling Online PodcastPodcast Archives - QA Selling Online PodcastTarik Berrada Co-founder and CSO at Chez M19 an AI-Powered Advertising Technology for Amazon sellers.Tarik Berrada Co-founder and CSO at Chez M19 an AI-Powered Advertising Technology for Amazon sellers. Are you in ParisTarik you are a data scientist?When did you realize you had a passion for data?How did all this get started?I see you have at m19 people who used to work at Google and a few ex Criteo and even a Former Senior Manager at Amazon Advertising, how did the team get together?I tried some ai companies before but one didn't even have ai, just bulk If then statements all performed once every 24 hours at 4 AmWhat do you love...2021-02-1738 min